RRM2 and cancer: RRM2 has been reported as a cancer driver as well as an oncogenic target, and its overexpression is also widely and critically expressed in various chemo-resistant tumors.32 Studies showed strong and ubiquitous RRM2 mRNA and protein expression in chemoresistance.